What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
John F. DiPersio focuses on Internal medicine, Transplantation, Immunology, Leukemia and Stem cell.
His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Endocrinology, Surgery and Oncology.
His Transplantation study combines topics in areas such as Plerixafor, Survival analysis and Granulocyte colony-stimulating factor.
His research on Immunology often connects related areas such as Cancer research.
The concepts of his Leukemia study are interwoven with issues in Myeloid, Myeloid leukemia, Chemotherapy and Somatic evolution in cancer.
His Myeloid leukemia study combines topics from a wide range of disciplines, such as Genetics, Mutation, Clonal architecture, Molecular biology and Comparative genomic hybridization.
His most cited work include:
- Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia (2799 citations)
- Recurring mutations found by sequencing an acute myeloid leukemia genome. (1798 citations)
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing (1522 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Transplantation, Immunology, Oncology and Surgery.
As part of the same scientific family, John F. DiPersio usually focuses on Internal medicine, concentrating on Gastroenterology and intersecting with Toxicity.
His research in Transplantation focuses on subjects like Plerixafor, which are connected to Hematopoietic Stem Cell Mobilization and Multiple myeloma.
John F. DiPersio interconnects Progenitor cell, Haematopoiesis and Stem cell in the investigation of issues within Immunology.
John F. DiPersio combines subjects such as Placebo and Cumulative incidence with his study of Surgery.
His work is dedicated to discovering how Leukemia, Cancer research are connected with Immunotherapy and other disciplines.
He most often published in these fields:
- Internal medicine (45.69%)
- Transplantation (30.80%)
- Immunology (28.44%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (45.69%)
- Cancer research (18.92%)
- Transplantation (30.80%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Cancer research, Transplantation, Oncology and Myeloid leukemia.
His Internal medicine study frequently draws connections to other fields, such as Gastroenterology.
His Cancer research research is multidisciplinary, incorporating perspectives in T cell, Antigen, Leukemia, CD3 and Immunotherapy.
His Transplantation study combines topics in areas such as Hematopoietic cell, Stem cell and Immunology.
The study incorporates disciplines such as Myeloid, Complete remission, Disease and Refractory in addition to Oncology.
The various areas that John F. DiPersio examines in his Myeloid leukemia study include Immune system and Bone marrow.
Between 2016 and 2021, his most popular works were:
- ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells (508 citations)
- Genomic and Functional Approaches to Understanding Cancer Aneuploidy (296 citations)
- Pathogenic Germline Variants in 10,389 Adult Cancers (273 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
John F. DiPersio mainly investigates Internal medicine, Transplantation, Oncology, Myeloid leukemia and Immunology.
His Gastroenterology research extends to Internal medicine, which is thematically connected.
His Transplantation study necessitates a more in-depth grasp of Surgery.
His work carried out in the field of Myeloid leukemia brings together such families of science as Adverse effect and Cohort.
His biological study spans a wide range of topics, including Haematopoiesis, Hematopoietic stem cell, Telomerase reverse transcriptase and Decitabine.
His Leukemia research integrates issues from Cancer research and Refractory.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
